Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
Journal
The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553
Informations de publication
Date de publication:
17 12 2021
17 12 2021
Historique:
received:
30
09
2020
accepted:
03
09
2021
pubmed:
19
11
2021
medline:
9
2
2022
entrez:
18
11
2021
Statut:
ppublish
Résumé
Venous resection of the superior mesenteric or portal vein is increasingly performed in pancreatic cancer surgery, whereas results of studies on short- and long-term outcomes are contradictory. The aim of this study was to evaluate the impact of the type of venous resection in pancreatoduodenectomy for pancreatic cancer on postoperative morbidity and overall survival. This nationwide retrospective cohort study included all patients who underwent pancreatoduodenectomy for pancreatic cancer in 18 centres (2013-2017). A total of 1311 patients were included, of whom 17 per cent underwent wedge resection and 10 per cent segmental resection. Patients with segmental resection had higher rates of major morbidity (39 versus 20 versus 23 per cent, respectively; P < 0.001) and portal or superior mesenteric vein thrombosis (18 versus 5 versus 1 per cent, respectively; P < 0.001) and worse overall survival (median 12 versus 16 versus 20 months, respectively; P < 0.001), compared to patients with wedge resection and those without venous resection. Multivariable analysis showed patients with segmental resection, but not those who had wedge resection, had higher rates of major morbidity (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to patients without venous resection. Among patients who received neoadjuvant therapy, there was no difference in overall survival among patients with segmental and wedge resection and those without venous resection (median 32 versus 25 versus 33 months, respectively; P = 0.470), although there was a difference in major morbidity rates (52 versus 19 versus 21 per cent, respectively; P = 0.012). In pancreatic surgery, the short- and long-term outcomes are worse in patients with venous segmental resection, compared to patients with wedge resection and those without venous resection.
Sections du résumé
BACKGROUND
Venous resection of the superior mesenteric or portal vein is increasingly performed in pancreatic cancer surgery, whereas results of studies on short- and long-term outcomes are contradictory. The aim of this study was to evaluate the impact of the type of venous resection in pancreatoduodenectomy for pancreatic cancer on postoperative morbidity and overall survival.
METHODS
This nationwide retrospective cohort study included all patients who underwent pancreatoduodenectomy for pancreatic cancer in 18 centres (2013-2017).
RESULTS
A total of 1311 patients were included, of whom 17 per cent underwent wedge resection and 10 per cent segmental resection. Patients with segmental resection had higher rates of major morbidity (39 versus 20 versus 23 per cent, respectively; P < 0.001) and portal or superior mesenteric vein thrombosis (18 versus 5 versus 1 per cent, respectively; P < 0.001) and worse overall survival (median 12 versus 16 versus 20 months, respectively; P < 0.001), compared to patients with wedge resection and those without venous resection. Multivariable analysis showed patients with segmental resection, but not those who had wedge resection, had higher rates of major morbidity (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to patients without venous resection. Among patients who received neoadjuvant therapy, there was no difference in overall survival among patients with segmental and wedge resection and those without venous resection (median 32 versus 25 versus 33 months, respectively; P = 0.470), although there was a difference in major morbidity rates (52 versus 19 versus 21 per cent, respectively; P = 0.012).
CONCLUSION
In pancreatic surgery, the short- and long-term outcomes are worse in patients with venous segmental resection, compared to patients with wedge resection and those without venous resection.
Identifiants
pubmed: 34791069
pii: 6430361
doi: 10.1093/bjs/znab345
pmc: PMC10364765
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
96-104Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.
Références
Surgery. 2011 May;149(5):680-8
pubmed: 21316725
Surgery. 2017 Feb;161(2):365-372
pubmed: 27692778
HPB (Oxford). 2014 Aug;16(8):691-8
pubmed: 24344986
J Clin Oncol. 2020 Jun 1;38(16):1763-1773
pubmed: 32105518
J Vasc Surg Venous Lymphat Disord. 2018 Jan;6(1):66-74
pubmed: 29128301
HPB (Oxford). 2017 Oct;19(10):919-926
pubmed: 28754367
HPB (Oxford). 2017 Nov;19(11):1001-1007
pubmed: 28838632
Br J Surg. 2019 May;106(6):765-773
pubmed: 30776085
Ann Oncol. 2019 May 1;30(5):781-787
pubmed: 30887043
J Vasc Surg. 2015 Aug;62(2):424-33
pubmed: 25953018
HPB (Oxford). 2021 Jan;23(1):80-89
pubmed: 32444267
HPB (Oxford). 2019 Jul;21(7):865-875
pubmed: 30606684
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
HPB (Oxford). 2020 Jan;22(1):50-57
pubmed: 31186199
Br J Surg. 2013 Sep;100(10):1349-56
pubmed: 23939847
Surgery. 2021 Feb;169(2):396-402
pubmed: 32868111
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
HPB (Oxford). 2015 Sep;17(9):824-31
pubmed: 26223388
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
Br J Surg. 2019 Nov;106(12):1649-1656
pubmed: 31626342
Ann Surg. 2020 Apr;271(4):e102-e104
pubmed: 32084037
HPB (Oxford). 2016 Jul;18(7):615-22
pubmed: 27346143
Ann Surg. 2015 Dec;262(6):1071-8
pubmed: 25590497
Ann Surg. 2020 Jan;271(1):155-162
pubmed: 31274651
Oncotarget. 2017 May 16;8(20):32600-32607
pubmed: 28427231
BJS Open. 2019 Jan 24;3(3):327-335
pubmed: 31183449
Br J Surg. 2017 Oct;104(11):1558-1567
pubmed: 28815556
Ann Oncol. 2015 Sep;26 Suppl 5:v56-68
pubmed: 26314780
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Br J Surg. 2017 Oct;104(11):1539-1548
pubmed: 28833055
Br J Surg. 2016 Feb;103(3):179-91
pubmed: 26663252
Surgery. 2007 Jul;142(1):20-5
pubmed: 17629996
Surgery. 2014 Jun;155(6):977-88
pubmed: 24856119
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
JAMA Surg. 2013 Apr;148(4):331-8
pubmed: 23715922
HPB (Oxford). 2018 Feb;20(2):140-146
pubmed: 29191690
J Gastrointest Surg. 2012 Oct;16(10):1869-74
pubmed: 22875597
J Gastrointest Surg. 2016 Mar;20(3):479-87; discussion 487
pubmed: 26768008
Surgery. 2014 Jul;156(1):1-14
pubmed: 24856668